Dynavax teams up with CEPI for Covid-19 vaccine

27 March 2020 (Last Updated March 27th, 2020 14:24)

Dynavax Technologies has partnered with the Coalition for Epidemic Preparedness Innovations (CEPI) to create a vaccine against Covid-19 infection.

The company will provide access to its toll-like receptor 9 (TLR9) agonist adjuvant, CpG 101, to enable the development of vaccines.

Read the full article here